LISBON, Portugal, Aug. 23, 2022 /PRNewswire/ Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome technology into the nutraceutical/dietary
/PRNewswire/ Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione s.